Xbrane Biopharma AB's total assets for Q1 2025 were kr696.32M, a decrease of -17.34% from the previous quarter. DE:7XB total liabilities were kr480.06M for the fiscal quarter, a -24.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.